Abstract
Deep vein thrombosis of the upper extremities and thoracic central veins may lead to superior vena cava (SVC) syndrome, pulmonary embolism, and post-thrombotic syndrome ( 1 Joffe H.V. Goldhaber S.Z. Upper-extremity deep vein thrombosis. Circulation. 2002; 106: 1874-1880 Crossref PubMed Scopus (232) Google Scholar ). The Inari ClotTriever thrombectomy system (Inari Medical, Irvine, California) is a Food and Drug Administration–approved system for thrombus removal from the peripheral and central veins. The system allows for single-session thrombectomy in patients with contraindications to pharmacological thrombolytic therapies. The technical aspects and required equipment have been previously described ( 2 Benarroch-Gampel J. Pujari A. Aizpuru M. Rajani R.R. Jordan W.D. Crawford R. Technical success and short-term outcomes after treatment of lower extremity deep vein thrombosis with the ClotTriever system: a preliminary experience. J Vasc Surg Venous Lymphat Disord. 2020; 8: 174-181 Abstract Full Text Full Text PDF PubMed Scopus (10) Google Scholar ). This report describes 2 patients who underwent thrombectomy for malignant thoracic central venous occlusive disease due to papillary thyroid and lung cancers using the ClotTriever system with technical and clinical successes. This series was conducted with an institutional review board approval and complied with the Health Insurance Portability and Accountability Act.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call